Stock Scorer

Biovie Inc. (BIVI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. This filer's financial year end could not be read from its revenue history, so quarters are labelled by the calendar. Amounts in USD. Every figure as a table ›

Revenue Quarterly

0 Q3 '15: 0 Q3 '16: 0 Q3 '15 Q3 '16

Operating Income Quarterly

-15M -10M -5M 0 5M 10M 15M Q3 '21: -5.5M Q4 '21: -6.7M Q1 '22: -5.7M Q2 '22: -9.3M Q3 '22: -8.8M Q4 '22: -11.5M Q1 '23: -13.8M Q2 '23: -11M Q3 '23: -10.9M Q4 '23: -8.8M Q1 '24: -7.7M Q2 '24: -4.8M Q3 '24: -4.1M Q4 '24: -7.3M Q1 '25: -3M Q2 '25: -3.7M Q3 '25: -5.3M Q4 '25: -6.3M Q1 '26: -5.4M Q2 '26: -5.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-18M -12M -6M 0 6M 12M 18M Q3 '21: -5.5M Q4 '21: -5.4M Q1 '22: -7M Q2 '22: -8.1M Q3 '22: -10.4M Q4 '22: -15.7M Q1 '23: -15M Q2 '23: -9.1M Q3 '23: -10.7M Q4 '23: -8.4M Q1 '24: -8.1M Q2 '24: -4.9M Q3 '24: -4.2M Q4 '24: -7.1M Q1 '25: -2.8M Q2 '25: -3.5M Q3 '25: -5.1M Q4 '25: -6.1M Q1 '26: -5.3M Q2 '26: -5.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-15M -10M -5M 0 5M 10M 15M Q3 '21: -2.5M Q4 '21: -4.7M Q1 '22: -5.9M Q2 '22: -5.9M Q3 '22: -9.2M Q4 '22: -8M Q1 '23: -11.7M Q2 '23: -11.3M Q3 '23: -12.2M Q4 '23: -5.9M Q1 '24: -5.9M Q2 '24: -4M Q3 '24: -3.6M Q4 '24: -8.6M Q1 '25: -1.3M Q2 '25: -5.6M Q3 '25: -3M Q4 '25: -4.4M Q1 '26: -7.4M Q2 '26: -4.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Shares Outstanding Quarterly

0 15M 30M 45M Q4 '19: 5.2M Q1 '20: 5.2M Q3 '20: 6M Q4 '20: 13.9M Q1 '21: 13.9M Q3 '21: 23.7M Q4 '21: 25M Q1 '22: 25M Q3 '22: 27.2M Q4 '22: 31.2M Q1 '23: 35.3M Q3 '23: 3.7M Q4 '23: 3.8M Q1 '24: 4.5M Q3 '24: 639.8K Q4 '24: 1.6M Q1 '25: 1.9M Q3 '25: 5.2M Q4 '25: 7.9M Q1 '26: 7.5M Q1 '20 Q1 '21 Q1 '22 Q1 '23 Q1 '24 Q1 '25 Q1 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-90.00 -60.00 -30.00 0.00 30.00 60.00 90.00 Q3 '21: -10.85 Q4 '21: -10.85 Q1 '22: -10.91 Q2 '22: -1.06 Q3 '22: -1.21 Q4 '22: -1.49 Q1 '23: -1.64 Q2 '23: -15.46 Q3 '23: -18.00 Q4 '23: -19.70 Q1 '24: -21.27 Q2 '24: -73.13 Q3 '24: -77.21 Q4 '24: -79.56 Q1 '25: -79.07 Q2 '25: -14.50 Q3 '25: -8.48 Q4 '25: -4.70 Q1 '26: -3.89 Q2 '26: -3.15 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

Not drawn for BIVI: Gross Profit, Cost of Revenue, Free Cash Flow. Nothing in this filer's XBRL supports them for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.